Barclays downgraded GSK (GSK) to Underweight from Equal Weight.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- GSK announces approval of Exdensur by Japan’s MHLW
- Kennedy scales back number of vaccines recommended for children, NYT says
- GSK announces China’s NMPA approved Nucala as add-on maintenance treatment
- Trump Weekly: Furniture tariffs delayed, drugmakers hike prices
- Midday Fly By: Nvidia said to see strong H200 demand in China